Atria Investments’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
13,681
+3,448
| +34% | +$302K | 0.01% | 1025 |
|
|
2026
Q1 | $925K | Buy |
10,233
+2,259
| +28% | +$207K | 0.01% | 1095 |
|
|
2025
Q4 | $717K | Sell |
7,974
-4,519
| -36% | -$428K | 0.01% | 1244 |
|
|
2025
Q3 | $1.23M | Buy |
12,493
+2,845
| +29% | +$282K | 0.01% | 942 |
|
|
2025
Q2 | $880K | Buy |
9,648
+470
| +5% | +$45.4K | 0.01% | 1103 |
|
|
2025
Q1 | $1.04M | Buy |
9,178
+820
| +10% | +$87.7K | 0.01% | 978 |
|
|
2024
Q4 | $883K | Buy |
8,358
+2,929
| +54% | +$314K | 0.01% | 1043 |
|
|
2024
Q3 | $586K | Buy |
5,429
+2,041
| +60% | +$223K | 0.01% | 1247 |
|
|
2024
Q2 | $368K | Buy |
+3,388
| New | +$399K | ﹤0.01% | 1465 |
|
|
2021
Q2 | – | Sell |
-11,098
| Closed | -$1.73M | – | 796 |
|
|
2021
Q1 | $1.73M | Sell |
11,098
-1,632
| -13% | -$253K | 0.04% | 508 |
|
|
2020
Q4 | $1.9M | Buy |
12,730
+1,012
| +9% | +$143K | 0.05% | 429 |
|
|
2020
Q3 | $1.55M | Buy |
11,718
+1,074
| +10% | +$140K | 0.05% | 415 |
|
|
2020
Q2 | $1.23M | Buy |
10,644
+448
| +4% | +$51.6K | 0.04% | 444 |
|
|
2020
Q1 | $1M | Buy |
10,196
+1,987
| +24% | +$260K | 0.08% | 229 |
|
|
2019
Q4 | $1.19M | Buy |
8,209
+1,920
| +31% | +$265K | 0.03% | 471 |
|
|
2019
Q3 | $838K | Sell |
6,289
-535
| -8% | -$69.1K | 0.03% | 473 |
|
|
2019
Q2 | $902K | Buy |
6,824
+108
| +2% | +$12.6K | 0.03% | 427 |
|
|
2019
Q1 | $833K | Buy |
6,716
+249
| +4% | +$28.3K | 0.04% | 402 |
|
|
2018
Q4 | $651K | Buy |
6,467
+515
| +9% | +$57.9K | 0.03% | 415 |
|
|
2018
Q3 | $760K | Buy |
+5,952
| New | +$708K | 0.03% | 474 |
|
|
2016
Q4 | – | Sell |
-1,715
| Closed | -$216K | – | 690 |
|
|
2016
Q3 | $216K | Sell |
1,715
-280
| -14% | -$34.6K | 0.02% | 488 |
|
|
2016
Q2 | $238K | Buy |
+1,995
| New | +$226K | 0.03% | 407 |
|
|
2015
Q3 | – | Sell |
-1,935
| Closed | -$205K | – | 414 |
|
|
2015
Q2 | $205K | Sell |
1,935
-338
| -15% | -$37.4K | 0.02% | 380 |
|
|
2015
Q1 | $259K | Sell |
2,273
-1,288
| -36% | -$147K | 0.03% | 351 |
|
|
2014
Q4 | $392K | Buy |
3,561
+751
| +27% | +$79.2K | 0.04% | 290 |
|
|
2014
Q3 | $274K | Sell |
2,810
-1,682
| -37% | -$165K | 0.03% | 385 |
|
|
2014
Q2 | $453K | Sell |
4,492
-12
| -0.3% | -$1.17K | 0.05% | 281 |
|
|
2014
Q1 | $414K | Buy |
4,504
+85
| +2% | +$7.83K | 0.04% | 314 |
|
|
2013
Q4 | $400K | Buy |
4,419
+52
| +1% | +$4.5K | 0.04% | 329 |
|
|
2013
Q3 | $348K | Buy |
4,367
+977
| +29% | +$76.9K | 0.04% | 335 |
|
|
2013
Q2 | $247K | Buy |
+3,390
| New | +$253K | 0.03% | 348 |
|
Other funds holding ZBH
Atria Investments's ZBH Position: Q2 2026 in Review
Atria Investments increased its Zimmer Biomet (ZBH) stake by 34% in Q2 2026, buying an estimated $302K and bringing the position to 13,681 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #1025.
Atria Investments first reported a position in ZBH in Q2 2013 and has held it in 31 quarters since. The position peaked at $1.9M in Q4 2020. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Atria Investments held 13,681 shares of Zimmer Biomet worth $1.18M as of Q2 2026.
- Atria Investments bought 3,448 Zimmer Biomet shares in Q2 2026, an estimated $302K.
- Zimmer Biomet made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1025 holding.
- Atria Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 31 quarters since.
- Atria Investments's Zimmer Biomet position peaked at $1.9M in Q4 2020.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.